Experimental drug could boost therapy against colorectal, lung, and other cancers
Researchers have identified a new radioactive substance called CB-2PA-NT as a promising candidate for a theranostics strategy, combining therapy and diagnostics. The substance, which targets neurotensin receptors found in various cancers, demonstrates high uptake and...
Read More